These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 301599)

  • 21. [A male case of autoimmune chronic active hepatitis (author's transl)].
    Ikeda K; Kawamura S; Fujita S; Matsumoto I; Kobayashi Y
    Nihon Naika Gakkai Zasshi; 1981 May; 70(5):734-9. PubMed ID: 6975337
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunological findings in hepatitis].
    Joller-Jemelka HI; Grob PJ
    Gastroenterol Fortbildungskurse Prax; 1975; 5():96-105. PubMed ID: 1083819
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevalence of circulating autoantibodies in healthy individuals].
    Teubner A; Tillmann HL; Schuppan D; Gericke G; Manns MP; Stölzel U
    Med Klin (Munich); 2002 Nov; 97(11):645-9. PubMed ID: 12434272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies in chronic hepatitis: diagnostic reagents and scientific tools to study etiology, pathogenesis, and cell biology.
    Manns MP
    Prog Liver Dis; 1994; 12():137-56. PubMed ID: 7746871
    [No Abstract]   [Full Text] [Related]  

  • 25. [Routine immunofluorescence studies for demonstration of antinuclear factors].
    Hiemann D
    Z Gesamte Inn Med; 1969 May; 24(10):150-1. PubMed ID: 4185287
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory tests for diagnosis of autoimmune diseases.
    Nakamura RM; Chisari FV; Edgington TS
    Prog Clin Pathol; 1975; 6():177-203. PubMed ID: 1105671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possible use of immunofluorescence in chronic agressive hepatitis].
    Storch W; Emmrich R
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(3):119-23. PubMed ID: 4599279
    [No Abstract]   [Full Text] [Related]  

  • 28. Antinuclear (chromatin) autoantibodies in autoimmune hepatitis.
    Mackay IR
    J Gastroenterol Hepatol; 2001 Mar; 16(3):245-7. PubMed ID: 11339413
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum beta 2-microglobulin (beta 2m) and anti-beta 2m antibody in chronic hepatitis.
    Pár A; Falus A
    Acta Med Hung; 1986; 43(4):343-9. PubMed ID: 3299246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral immunity in chronic liver disease.
    Simon K; Patakfalvi A; Pár A; Miszlay Z
    Acta Med Acad Sci Hung; 1973; 30(4):283-92. PubMed ID: 4134638
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical significance of the study of antibodies and complement in chronic hepatopathies].
    Naccarato R; Farini R; Chiaramonte M
    Minerva Med; 1978 Aug; 69(38):2573-9. PubMed ID: 309566
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis.
    Mackay IR; Frazer IH; Toh BH; Pedersen JS; Alter HJ
    Clin Exp Immunol; 1985 Jul; 61(1):39-43. PubMed ID: 3930108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrence of ulcerative colitis and chronic acitve hepatitis, Clinical courses and results of colectomy.
    Olsson R; Hultén L
    Scand J Gastroenterol; 1975; 10(3):331-5. PubMed ID: 1079628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiperinuclear and antikeratin antibodies in liver diseases].
    Youinou P; Miossec P; Pennec Y; Boles JM; Le Goff P; Le Menn G
    Sem Hop; 1983 Mar; 59(9):589-92. PubMed ID: 6190231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitissue antibodies in hepatology].
    Homberg JC
    Gastroenterol Clin Biol; 1985; 9(8-9):622-9. PubMed ID: 3908208
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
    Todros L; Saracco G; Durazzo M; Abate ML; Touscoz G; Scaglione L; Verme G; Rizzetto M
    Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is there a relationship between the presence of autoantibodies or mixed cryoglobulinemia and the clinical and histological characteristics of chronic viral hepatitis C?].
    Rolachon A; Pasquier D; Girard M; Arvieux J; Bichard P; Bensa JC; Zarski JP
    Gastroenterol Clin Biol; 1994; 18(3):251-6. PubMed ID: 7926441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autoantibodies in the diagnosis of autoimmune diseases of the liver].
    Cançado EL; de Oliveira RM; da Silva LC
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):253-8. PubMed ID: 2700108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for autoantibodies in human subjects immunized with Pr-beta-HCG-TT.
    Nath I; Whittingham S; Lambert PH; Talwar GP
    Contraception; 1976 Feb; 13(2):225-30. PubMed ID: 1081938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.